A verified, campaign-ready database is available featuring cancer immunotherapy researchers, oncologists, physician-scientists, biotechnology and pharmaceutical professionals, clinical researchers, and healthcare decision-makers attending and exhibiting at the SITC 2026 Annual Meeting Attendees List in Phoenix, Arizona.
The SITC 2026 Annual Meeting Attendees List and Pre-Conference Programs, the 41st iteration of this event, will be held November 4 to 8, 2026, at the Phoenix Convention Center with an option for virtual participation. This meeting convenes researchers, clinicians, industry representatives, government officials, and early-career scientists dedicated to cancer immunotherapy.
Whether you offer biotechnology solutions, pharmaceutical products, medical devices, laboratory equipment, data and informatics services, research solutions, or scientific supplies, the ExpoLake SITC 2026 Contact List supports targeted sales and marketing outreach to relevant industry professionals.
Verified Attendees
Exhibiting Companies
Accuracy
Delivery Time
Verification Layers
The Annual Meeting and Pre-Conference Programs of SITC 2026 will bring together leading researchers, clinicians, professionals from the industry, government representatives, and early-career scientists who are committed to promoting cancer immunotherapy. The 41st annual meeting will take place from 4 to 8 November 2026 at the Phoenix Convention Center in Phoenix, Arizona, with the possibility of taking part virtually.
The meeting provides a multidisciplinary forum for the exchange of scientific ideas, with a focus on basic, translational, and clinical research, together with oral and poster presentations, interaction with the industry, educational sessions, and opportunities for networking among members of the global cancer immunotherapy community.
The event will feature companies and organizations that are involved in biotechnology, pharmaceuticals, medical devices and equipment, data management, informatics, research services, scientific supplies, medical publishing, and cancer research institutions.
The SITC 2026 Annual Meeting convenes organizations across the cancer immunotherapy ecosystem, including biotechnology and pharmaceutical companies, medical technology providers, research organizations, data and informatics firms, scientific suppliers, and healthcare institutions.
Biotechnology companies engaged in developing cancer immunotherapies, cellular therapies, biomarkers, research technologies, and life sciences solutions.
Pharmaceutical and biopharma companies showcasing oncology therapeutics, immunotherapies, clinical development programs, and related healthcare solutions.
Medical device manufacturers and equipment providers supporting cancer research, laboratory workflows, clinical applications, and immunotherapy development.
Companies offering data management, bioinformatics, analytical platforms, computational tools, and research data solutions to support immuno-oncology.
Research companies, agencies, and scientific supply providers offering laboratory products, research services, reagents, technologies, and specialized scientific solutions.
Medical publishers, cancer organizations, universities, hospitals, and research institutions advancing scientific communication, education, and cancer immunotherapy research.
Researchers carried out basic, translational, and clinical research concentrating on cancer immunology, tumor biology, and immunotherapy.
Doctors, clinical researchers, and physicians who are looking at the recent developments in immunotherapy research and its clinical applications.
The physicians who are also scientists, pharmacists, nurses, and other health professionals taking part in cancer treatment and research projects.
Leaders in the field of research and development, scientists, medical affairs professionals, and business executives from biotechnology and pharmaceutical companies.
People from regulatory agencies, government organizations, and public-sector institutions who are involved in cancer research and the development of therapies.
Students who are pursuing a graduate degree, those who have been appointed as postdoctoral fellows, early-career researchers, and younger scientists who are developing their expertise in the field of cancer immunotherapy.
The SITC 2026 Annual Meeting Attendees List provides business and professional contact data for cancer immunotherapy researchers, clinicians, biotechnology and pharmaceutical professionals, medical technology providers, research organizations, and other industry decision-makers.
Each record can include essential contact and company information to help your team identify relevant prospects and build targeted B2B marketing campaigns.
Core Data Fields in Our SITC 2026 Annual Meeting Attendees List
These data fields can help segment contacts by organization type, professional role, industry, location, company size, and cancer immunotherapy specialization for targeted outreach. SITC’s official audience includes academic investigators, clinicians, biotechnology and pharmaceutical professionals, regulatory agencies, researchers, graduate students, postdoctoral fellows, allied health professionals, pharmacists, and payers.
Engage researchers, clinicians, biotechnology professionals, pharmaceutical executives, and other key decision-makers in the field of cancer immunotherapy.
Obtain high-quality business contact information to enable precise prospecting and targeted B2B outreach.
Use the database for email campaigns, LinkedIn outreach, appointment setting, ABM, and post-meeting follow-ups.
Access contact and company details, including job title, organization, industry, location, company size, and professional specialization.
Segment prospects based on organization type, industry, job function, seniority level, geographic region, and immunotherapy specialization.
Receive stReceive structured contact data in Excel or CSV formats for seamless integration with CRM systems and marketing workflows.
Get verified attendee and exhibitor contact lists from past and upcoming event editions worldwide. ExpoLake delivers accurate, segmented B2B contact data covering key decision-makers and exhibiting companies, so your outreach always reaches the right person at the right time.
We would like for you to ask for a free sample of the list of ExpoLake SITC 2026 Annual Meeting Attendees List before you make a purchase.
Provide a preview of sample contacts who are involved in cancer immunotherapy, including researchers, clinicians, oncologists, professionals from the biotechnology and pharmaceutical sectors, providers of medical technology, and research organizations. The database is set up to assist with targeted email marketing, LinkedIn outreach, arranging appointments, and business-to-business sales campaigns.
Our sample shows the kinds of contact details and company information available, such as names, job titles, business email addresses, phone numbers, company names, industries, locations, company size, revenue, and professional specialization.
Engage with cancer researchers, clinicians, biotechnology professionals, pharmaceutical executives, and other experts specializing in cancer immunotherapy.
Present your products, services, or research solutions to targeted prospects and build professional relationships before the meeting.
Interact with professionals engaged in cancer immunotherapy research, clinical implementation, and emerging technology development.
Network with professionals representing biotechnology, pharmaceutical, medical device, informatics, research, and scientific supply sectors.
Follow up with relevant prospects after SITC 2026 to nurture relationships and create long-term business opportunities.
Enhance targeted pre-event and post-event campaigns using segmented business contact data tailored to your ideal audience.
Every contact in the ExpoLake database goes through a structured, multi-step sourcing and verification process before it reaches your team. Here is how we build data you can trust.
Contacts are gathered from trade shows, global directories, e-books, newsletters, and digital publications spanning dozens of industries and regions.
Machine learning fills missing fields, appends firmographic data, and segments contacts by industry, role, company size, and intent signals — automatically.
Every record is cross-checked against our master database and validated via social platforms, public registries, and news sources to confirm authenticity.
Anomalies, duplicates, and stale entries are flagged using statistical models and eliminated. A final manual audit ensures the highest standard of data quality.
A/B-tested opt-in email sequences are deployed to capture and confirm explicit consent, fully aligned with GDPR, CAN-SPAM, and CASL compliance frameworks.
A final tele-verification call confirms all data fields. Only fully validated, consented records are released to the client — clean, compliant, and ready to use.
The list of attendees and exhibitors at the SITC 2026 Annual Meeting Attendees List is a business contact database which is designed to help people identify professionals and organisations in the fields of cancer immunotherapy, biotechnology, the pharmaceutical industry, research, and healthcare.
The database allows for outreach to be directed at researchers, clinicians, oncologists, physician-scientists, professionals in the biotechnology and pharmaceutical industries, regulatory professionals, pharmacists, and other healthcare and life-science professionals.
The meeting brings together organisations and professionals from the fields of academia, government, biotechnology, pharmaceuticals, healthcare, research and those related to cancer immunotherapy.
Certainly. The database does provide the facility of segmentation, allowing one to focus on people in the biotechnology, biopharmaceutical, pharmaceutical, research and development, and other life-science fields.
Yes. Contact segments may be customized according to job title, industry, geographic location, company size, revenue, and professional specialization.